Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

CMS proposed rule would boost Medicare inpatient rates by 2.6%

CMS has issued a proposed rule that would result in a net increase of 2.6% to the Medicare inpatient prospective payment system rate for fiscal year 2025, a raise that hospital trade groups say doesn’t go far enough.

Medicare money payment physician

Critics call out ‘woefully inadequate’ CMS proposal for inpatient Medicare payments

CMS has issued its proposed rule for the 2025 Medicare hospital inpatient prospective payment system, suggesting a payment increase of 2.6%. According to the American Hospital Association, this update would not be enough at a time when hospitals are already struggling to stay open. 

MPT completes 5-hospital sale to Prime Healthcare

Included in the real estate exchange is St. Francis Medical Center in California and Saint Clare's Health network of acute and behavioral facilities in New Jersey.

physician money payments dollars

Payments to FDA advisory panel questioned

A recent investigation from KFF Health News about payments to members of an FDA panel evaluating an Abbott Laboratories cardiac device is raising eyebrows.

healthcare AI code of conduct

Submitted for consideration by all healthcare AI stakeholders: 10 principles, 6 commitments, 1 direction

Key collaborators across the healthcare AI life cycle now have a common set of principles to which they can hold each other. And that means everyone from developers and researchers to providers, regulators and even patients.

CMS drug price negotiations

Drug price dialogues represent ‘an opportunity for CMS to clarify negotiation policies and their potential impact for the future’

CMS must ensure transparency, clarity and predictability by providing detailed guidance on comparator drug selection and the evaluation of evidence, according to a group of D.C.-based health policy researchers.

New York Times artificial intelligence training data

The well for AI training data is running dry. Big Tech heavyweights are taking extraordinary measures to deal with the drought.

Bumping up hard against the reality of depleted data sources, three of AI’s top players have been acting like they’ve had no choice but to consider cutting corners.

academic medical centers financial health

How teaching hospitals can recover fiscal fitness

Two-fifths of leaders at academic medical centers, 41%, see reducing average length of patient stay as far and away the No. 1 “most untapped” strategy to turn around falling operating margins.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.